US Bancorp’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Sell |
35,804
-3,823
| -10% | -$22.1K | ﹤0.01% | 1997 |
|
|
2025
Q1 | $262K | Buy |
39,627
+17,523
| +79% | +$116K | ﹤0.01% | 1855 |
|
|
2024
Q4 | $193K | Buy |
22,104
+14,335
| +185% | +$125K | ﹤0.01% | 2044 |
|
|
2024
Q3 | $152K | Sell |
7,769
-1,410
| -15% | -$27.6K | ﹤0.01% | 2180 |
|
|
2024
Q2 | $189K | Buy |
9,179
+543
| +6% | +$11.2K | ﹤0.01% | 2033 |
|
|
2024
Q1 | $184K | Buy |
8,636
+6,539
| +312% | +$139K | ﹤0.01% | 2050 |
|
|
2023
Q4 | $30.2K | Buy |
2,097
+651
| +45% | +$9.36K | ﹤0.01% | 2886 |
|
|
2023
Q3 | $13.2K | Buy |
1,446
+354
| +32% | +$3.23K | ﹤0.01% | 3057 |
|
|
2023
Q2 | $11.6K | Buy |
1,092
+207
| +23% | +$2.19K | ﹤0.01% | 3182 |
|
|
2023
Q1 | $10.8K | Sell |
885
-736
| -45% | -$9K | ﹤0.01% | 3240 |
|
|
2022
Q4 | $20.1K | Buy |
1,621
+177
| +12% | +$2.2K | ﹤0.01% | 2976 |
|
|
2022
Q3 | $20K | Buy |
1,444
+1,310
| +978% | +$18.1K | ﹤0.01% | 3003 |
|
|
2022
Q2 | $2K | Sell |
134
-480
| -78% | -$7.16K | ﹤0.01% | 3819 |
|
|
2022
Q1 | $10K | Buy |
+614
| New | +$10K | ﹤0.01% | 3352 |
|
|
2021
Q4 | – | Sell |
-847
| Closed | -$16K | – | 4125 |
|
|
2021
Q3 | $16K | Buy |
847
+547
| +182% | +$10.3K | ﹤0.01% | 3216 |
|
|
2021
Q2 | $7K | Buy |
300
+284
| +1,775% | +$6.63K | ﹤0.01% | 3502 |
|
|
2021
Q1 | $0 | Sell |
16
-61
| -79% | – | ﹤0.01% | 3881 |
|
|
2020
Q4 | $3K | Buy |
+77
| New | +$3K | ﹤0.01% | 3475 |
|